Patient Support

Including patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.

A non-randomized control trial investigates whether older adults with multiple chronic conditions can benefit by receiving more specialized services.

As providers and healthcare professionals recognize the potential of long-acting injectables to fight the opioid epidemic, many are actively transitioning from oral options to injectables.

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.

The group—known as the Innovators' Network—is meant to serve as a link between entrepreneurs, providers, researchers, and payers while they strive to combat cardiovascular disease.

While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector.

Study examines the parallels between doctorate students and the US population.

How pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.

In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.

Breakout session summarizes key areas that will affect all aspects of the industry.

Session discusses ways to integrate digital pharmacies and hubs.

Panel uncovers ways to handle the increasing complexities and risks surrounding commercialization.

To rebuild trust, companies should utilize a customer-centric approach, focusing on transparent and neutral content incorporating medical expertise and regularly seeking HCP feedback.

Will result from Medicare reforms, despite increased drug uptake.

Methods that pharma companies can use to make the hub more personalized and experiential.

How to provide effective brand engagement in this rocky yet emerging landscape.

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

Study emphasizes role in bridging research and development and commercial/marketing functions.

Digital twins allow the industry to integrate sustainable practices and supply chain efficiency solutions while ensuring patient safety.

ClearNetwork will be available for a plan sponsor’s list of covered generic, branded, and specialty drugs across 65,000 retail pharmacies in the Express Scripts network.

New initiative highlights importance of a collaborative approach that allows patients to share their insights and contribute value to studies.

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle.